--------------------
continue
AVGs
AVFs
AVGs
AVFs
pharmacomechanical
rheolytic
AVGs
AVFs
--------------------
human
65–85
hemoconcentration
Cannulation
REF].Thrombosed
Thrombus
Thrombosed
--------------------
create
Thrombosed
AVGs
AVFs
Embolectomy
rheolytic
AVGs
AVFs
--------------------
explain
AVFs
AVGs
AVGs
AVFs
--------------------
human
disease-2019
78%.5
CSDH)8
--------------------
continue
--------------------
explain
--------------------
create
disease-2019
--------------------
human
immunoregulation
eATP
eATP
eATP
purinoceptor
eATP
eADO
ectonucleotidases
REF].eADO
signaling.eADO
eATP
ectonucleotidases
eATP
CD39
ectonucleoside
diphosphohydrolase
eADO
CD73
5′-nucleotidase
eAMP
eADO
eAMP
eATP
NDPK
REF].The
eADO
ectohydrolase
CD203a
ectonucleotide
--------------------
explain
eADO
eATP
eATP
eATP
purinoceptor
eATP
eADO
ectonucleotidases
eADO
CD39
ectonucleoside
diphosphohydrolase
CD73
5'-nucleotidase
eADO
ectohydrolase
CD203a
ectonucleotide
eADO
eADO
CD39
CD73
eADO
--------------------
create
eADO
eADO
eATP
eATP
eADO
eATP
eADO
adenosinergic
adenosinergic
adenosinergic
adenosinergic
--------------------
continue
adenosinergic
eADO
eADO
eATP
eATP
eATP
eADO
eADO
eATP
eADO
adenosinergic
adenosinergic
adenosinergic
eADO
adenosinergic
eADO
adenosinergic
--------------------
human
REF]).Detailed
sarcopenic
--------------------
continue
Jentoft
AgeiNg
ENHANce
aLM
aLM
SarQoL
sarcopenic
--------------------
create
Jentoft
Gammone
Simopoulos
AgeiNg
ENHANce
SarQoL
ENHANce
sarcopenic
--------------------
explain
sarcopenic
--------------------
create
immunopathological
--------------------
human
PASC.The
https://recovercovid.org/protocols
PASC.The
--------------------
explain
Biospecimens
--------------------
continue
immunopathological
immunopathological
AVGs
AVFs
AVGs
AVFs
Thrombectomy
rheolytic
AVGs
AVFs
65–85
hemoconcentration
Cannulation
REF].Thrombosed
Thrombus
Thrombosed
Thrombectomy
AVGs
AVFs
AVGs
AVFs
3.a
3.b
5.a
5.b
Thrombectomy
rheolytic
5.c
AVFs
AVGs
AVFs
AVGs
AVFs
hemoconcentration
Thrombosed
Thrombus
disease-2019
78%.5
CSDH)8
CSDH
invoked[5].It
disease-2019
Khazanchi
Filgate
CovidTracker
CovidTrek
Wibbelsman
adherence(Rubalcava
2021;WHO),ultimately
immunoregulation
eATP
eATP
eATP
purinoceptor
eATP
eADO
ectonucleotidases
REF].eADO
signaling.eADO
eATP
ectonucleotidases
eATP
CD39
ectonucleoside
diphosphohydrolase
eADO
CD73
5′-nucleotidase
eAMP
eADO
eAMP
eATP
NDPK
REF].The
eADO
ectohydrolase
CD203a
ectonucleotide
eATP
eADO
eATP
eADO
immunoregulation
eATP
eATP
eATP
purinoceptor
eATPs
eADO
ectonucleotidases
CD39
ectonucleoside
diphosphohydrolase
eATP
CD73
5′-nucleotidase
eADO
eADO
CD203a
eADO
CD73
eAMP
eADO
eADO
CD39
CD73
CD73
eADO
adenosinergic
eADO
adenosinergic
eADO
eADO
eATP
eATP
eATP
eADO
A1,A2A
eATP
eADO
eATP
eATO
P1and
ectonucleotidases
CD39
CD73
prognosis-
eATP
eADO
adenosinergic
concentration(securing
eADO
CD73
REF]).Detailed
sarcopenic
AgeiNg
ENHANce
sarcopenic
aLM
SarQoL
ENHANce
Jentoft
Demontiero
ENHANce
ENHANce
sarcopenic
sarcopenic
sarcopenic
sarcopenic
EWGSOP2
sarcopenic
Sequelae
PASC.The
https://recovercovid.org/protocols
PASC.The
thrombogenic
hyperinflammatory
immunopathological
